These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 19687782)

  • 1. Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene.
    Hsiao DJ; Wu LS; Huang SY; Lin E
    Pharmacogenet Genomics; 2009 Sep; 19(9):730-3. PubMed ID: 19687782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine.
    Vazquez Roque MI; Camilleri M; Clark MM; Tepoel DA; Jensen MD; Graszer KM; Kalsy SA; Burton DD; Baxter KL; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):829-37. PubMed ID: 17544870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the common -866G/A polymorphism of the uncoupling protein 2 gene on weight loss and body composition under sibutramine therapy in an obese Taiwanese population.
    Hsiao TJ; Wu LS; Hwang Y; Huang SY; Lin E
    Mol Diagn Ther; 2010 Apr; 14(2):101-6. PubMed ID: 20359253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the G-protein β3 subunit 825T allele on the change of body adiposity in obese female.
    Hwang IC; Kim KK; Ahn HY; Suh HS; Oh SW
    Diabetes Obes Metab; 2013 Mar; 15(3):284-6. PubMed ID: 23061407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.
    Early JL; Apovian CM; Aronne LJ; Fernstrom MH; Frank A; Greenway FL; Heber D; Kushner RF; Cwik KM; Walch JK; Hewkin AC; Blakesley V
    Obesity (Silver Spring); 2007 Jun; 15(6):1464-72. PubMed ID: 17557984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients.
    Faria AN; Ribeiro Filho FF; Kohlmann NE; Gouvea Ferreira SR; Zanella MT
    Diabetes Obes Metab; 2005 May; 7(3):246-53. PubMed ID: 15811141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight loss and quality of life improvement in obese subjects treated with sibutramine: a double-blind randomized multicenter study.
    Di Francesco V; Sacco T; Zamboni M; Bissoli L; Zoico E; Mazzali G; Minniti A; Salanitri T; Cancelli F; Bosello O
    Ann Nutr Metab; 2007; 51(1):75-81. PubMed ID: 17356258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
    de Simone G; Romano C; De Caprio C; Contaldo F; Salanitri T; di Luzio Paparatti U; Pasanisi F
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism.
    Hauner H; Meier M; Jöckel KH; Frey UH; Siffert W
    Pharmacogenetics; 2003 Aug; 13(8):453-9. PubMed ID: 12893983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine.
    Hainer V; Kunesova M; Bellisle F; Hill M; Braunerova R; Wagenknecht M
    Int J Obes (Lond); 2005 Feb; 29(2):208-16. PubMed ID: 15583700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of moderate weight loss on health-related quality of life: an analysis of combined data from 4 randomized trials of sibutramine vs placebo.
    Samsa GP; Kolotkin RL; Williams GR; Nguyen MH; Mendel CM
    Am J Manag Care; 2001 Sep; 7(9):875-83. PubMed ID: 11570021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sibutramine in overweight, poorly controlled Chinese female type 2 diabetic patients: a randomised, double-blind, placebo-controlled study.
    Wang TF; Pei D; Li JC; Tsai WC; Tsai CC; Yao CY; Chang ET; Hsieh MC; Su KY; Kuo SW
    Int J Clin Pract; 2005 Jul; 59(7):746-50. PubMed ID: 15963197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the C825T polymorphism of the GNB3 gene on body adiposity and blood pressure in fertile and menopausal women: a population-based study.
    Casiglia E; Tikhonoff V; Caffi S; Martini B; Guidotti F; Bolzon M; Bascelli A; D'Este D; Mazza A; Pessina AC
    J Hypertens; 2008 Feb; 26(2):238-43. PubMed ID: 18192837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea.
    Yee BJ; Phillips CL; Banerjee D; Caterson I; Hedner JA; Grunstein RR
    Int J Obes (Lond); 2007 Jan; 31(1):161-8. PubMed ID: 16652122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orlistat and sibutramine beyond weight loss.
    Mannucci E; Dicembrini I; Rotella F; Rotella CM
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):342-8. PubMed ID: 17928208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hunger and mood during extended fasting are dependent on the GNB3 C825T polymorphism.
    Michalsen A; Frey UH; Merse S; Siffert W; Dobos GJ
    Ann Nutr Metab; 2009; 54(3):184-8. PubMed ID: 19420911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).
    Sharma AM; Caterson ID; Coutinho W; Finer N; Van Gaal L; Maggioni AP; Torp-Pedersen C; Bacher HP; Shepherd GM; James WP;
    Diabetes Obes Metab; 2009 Mar; 11(3):239-50. PubMed ID: 18671798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sibutramine improves fat distribution and insulin resistance, and increases serum adiponectin levels in Korean obese nondiabetic premenopausal women.
    Kim DM; Yoon SJ; Ahn CW; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S139-44. PubMed ID: 15563965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic-leptin relationship in obesity: effect of weight loss.
    Quilliot D; Böhme P; Zannad F; Ziegler O
    Metabolism; 2008 Apr; 57(4):555-62. PubMed ID: 18328360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.